Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
L-Kvercet
- Development stage
- Unknown
- Lead developer
- Farmstandart-Biolik
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
L-Kvercet is a liposomal oral suspension of quercetin developed and manufactured by Biolik (Farmstandart-Biolik) in Ukraine. Formulated as a dietary supplement, it delivers quercetin in a liposomal delivery system to enhance bioavailability, alongside the amino acid glycine. Quercetin is a natural plant flavonoid with potent antioxidant, anti-inflammatory, and cardioprotective properties. It acts as a pleiotropic inhibitor of key inflammatory and oxidative enzymes, including arachidonate 5-lipoxygenase (ALOX5), cyclooxygenase-2 (COX-2), and phosphatidylinositol 3-kinase (PI3K). L-Kvercet is approved and marketed in Ukraine for the normalization of cardiovascular function, as a supportive agent during post-stroke and post-operative rehabilitation, for the repair of gastrointestinal erosions and ulcers, and for respiratory protection against oxidative stress.
- Brand names
- L-KvercetЛ-Кверцет
- Other names
- liposomal quercetinquercetin liposomal
02
Targets
ALOX5 (Arachidonate 5-lipoxygenase)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)PI3K (Phosphoinositide-3-kinase regulatory subunit 6)
Beyond the preview
Go deeper on L-Kvercet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on L-Kvercet.